Position in SCYX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,450
+$1,699 QoQ
Shares Held
602
+490.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 39 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCYX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $624,876,791 across 66 Drug Manufacturers - Specialty & Generic names. SCYX ranks #55 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
9,213,269 | $133,500,266 | |
| 2 | ZTS |
Zoetis Inc.
|
1,828,326 | $131,383,499 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
583,476 | $98,339,041 | |
| 4 | BHC |
Bausch Health Companies Inc.
|
10,832,582 | $53,404,627 | |
| 5 | VTRS |
Viatris Inc
|
3,135,460 | $49,791,098 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
62,600 | $33,918,552 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
953,413 | $32,301,629 | |
| 8 | HLN |
Haleon plc
|
3,385,489 | $31,586,609 |
All Filings in SCYX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,450 | 602 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $751 | 820 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $437 | 692 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $84 | 110 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $952 | 1,000 | Shares | Defined | 2025-11-21 | |
| 2023-12-31 | $37,464 | 16,800 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $38,304 | 16,800 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $283 | 96 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,500 | 500 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $234 | 150 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $369 | 154 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $1,603 | 410 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,501 | 410 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,173 | 410 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,017 | 410 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,461 | 310 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $2,371 | 310 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,371 | 311 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,119 | 4,154 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,987 | 3,826 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||